Data from - Curated by EPG Health - Date added 04 April 2019

The 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) will take place in Amsterdam, Netherlands, from 13 - 16 April 2019. It brings together experts from many fields to present their latest findings, guidelines and experiences to an audience of over 12,000 colleagues and also includes the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) event.

Featured keynote lectures :

  • Biomedical prophylaxis of HIV and other sexually transmitted infections: a change of paradigm?, Collaborating with the innate immune system to treat antibiotic-resistant superbugs and Hepatitis B therapy pipeline: how far are we from cure?

Featured integrated Symposium:

  • Pfizer - Vaccines throughout life: updates on pneumococcal, meningococcal and tick-borne encephalitis vaccination, MSD - Cytomegalovirus prophylaxis: the new paradigm, MSD - Addressing the burden of Clostridium difficile infection: a focus on prevention of recurrence, Menarini - Update on acute bacterial skin and skin structure infection: current challenges and new therapeutic agents

Further details can be found on the ECCMID website here.


You will need to login, to leave a comment. is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more



See information on best practice in solid organ transplantation, and expert discussions on related hot topics.



See information on psoriasis pathophysiology, signs and symptoms, comorbidities, treatment options, and more.

+ 2 more

Load more

Related Content